Background: Hyperphosphataemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder caused by impaired FGF-23 signalling, resulting in persistent hyperphosphataemia and progressive peri-articular calcium phosphate deposition. Acute inflammatory flares may mimic infection, creating a diagnostic and therapeutic challenge. We report the use of interleukin-1 receptor blockade with anakinra for an acute sterile inflammatory flare of HFTC in a child.
Case Presentation: An 11-year-old girl with genetically confirmed HFTC (homozygous GALNT3 c.1244A>G, p.(His415Arg)) presented with several days of progressive, painful bilateral elbow swelling, warmth and markedly restricted range of motion. She reported subjective fever at home and had spontaneous rupture of a left elbow lesion with thick yellowish, blood-tinged discharge. She was afebrile and haemodynamically stable on examination, with no systemic features of sepsis.
Initial investigations demonstrated marked hyperphosphataemia (2.91 mmol/L), elevated C-terminal FGF-23 (1292 relative units), low alkaline phosphatase, and an inflammatory response (CRP 86.8 mg/L, ESR 86 mm/hr). Procalcitonin was low at 0.17 ng/mL. Radiographs demonstrated large amorphous peri-articular calcified masses without evidence of osteomyelitis, while ultrasound showed thick-walled calcified lesions without a drainable abscess. Wound swab and aspirated peri-articular fluid were sterile. Although intravenous clindamycin was commenced empirically for suspected septic arthritis/soft-tissue infection, persistent clinical stability, sterile cultures, low procalcitonin and imaging findings supported a sterile inflammatory flare.
Following multidisciplinary discussion and exclusion of infection, anakinra 100 mg subcutaneously once daily was initiated on day 7. Phosphate-lowering therapy was intensified with sevelamer and acetazolamide, alongside dietary intervention. Within 48–72 hours, there was marked improvement in pain, swelling and elbow range of motion, with no further discharge. Inflammatory markers improved substantially (CRP 16.1 mg/L, procalcitonin 0.08 ng/mL, ESR 46 mm/hr). The patient was discharged functionally recovered, with near-full elbow movement and no reported adverse effects from anakinra.
Learning Points: Acute inflammatory flares in HFTC can closely resemble septic arthritis or soft-tissue infection and require careful clinical, microbiological and radiological assessment to avoid unnecessary prolonged antimicrobial therapy. In this case, the rapid clinical and biochemical response following IL-1 receptor blockade supports a role for IL-1-mediated inflammation in sterile HFTC flares. Anakinra may be a useful therapeutic option when infection has been confidently excluded. Recognition of the underlying FGF-23-related phosphate-handling defect and coordinated multidisciplinary management are essential for both acute and long-term care.

